|
|
|
|
|
|
|
Tuesday, 6 December, 2011
|
14:15 -
15:10
|
- Role of Regulatory Bodies
- Lessons Learned from Bench to Bedside
|
|
Dr. Nadia Cheaib
President
Middle East Clinical Research Association (MECRA)
Lebanon
|
|
|
|
15:15 -
16:10
|
- How can Pharma companies raise awareness and improve compliance of the public in managing NCDs
- Explore implementation of data standards and the need to access a shared data base
- Behavior change innovations to motivate people to increase control over their health and adopt healthy behaviors
|
|
|
Emil Kongshøj Larsen
Vice President, Global Public Affairs
Novo Nordisk A/S
Denmark
|
|
|
|
|
|
13:30 -
14:25
|
- How do Pharma Companies illustrate value for medicine to health care facilities
- Determine how payers set reimbursement on new therapeutic drugs
- Differentiate products through cost and effectiveness data
|
|
|
Sally Jeffery
Partner
PricewaterhouseCoopers
United Arab Emirates
|
|
|
|
14:30 -
15:30
|
- Assess payer reimbursement patterns
- Ensure that drug therapy meets current standards of care
|
|
|
|
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page